Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Berlan

Showing results (81-90 of 141) with videos related to

Pageof 15
Sort By:
British Journal of Pharmacology|August 1, 1990
Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxanJ Galitzky, J M Senard, M Lafontan, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 16, 2002
Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese womenC Sengenes, V Stich, M Berlan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462J S Saulnier-Blache, M Taouis, M Dauzats, et al.
British Journal of Pharmacology|February 1, 1991
Yohimbine increases submaxillary kallikrein release into the saliva in dogs: evidence for alpha 2-adrenoceptor-mediated inhibition of cholinergic pathwaysJ P Girolami, J L Bascands, C Pécher, et al.
British Journal of Clinical Pharmacology|July 1, 1993
Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in manP Barbe, J Galitzky, D Riviere, et al.
European Journal of Clinical Investigation|December 1, 1985
Platelet alpha 2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatmentA Villeneuve, M Berlan, M Lafontan, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 24, 1999
Increase in epinephrine-induced responsiveness during microgravity simulated by head-down bed rest in humansP Barbe, J Galitzky, C Thalamas, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case reportJ M Senard, A Arias, M Berlan, et al.
Fundamental & Clinical Pharmacology|September 21, 2001
Changes in vascular alpha 1- and alpha 2-adrenoceptor responsiveness by selegiline treatmentM Pelat, P Verwaerde, M A Tran, et al.
Clinical Neuropharmacology|December 1, 1990
Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatmentG Durrieu, Y Rispail, E Chatelut, et al.
Pageof 15

Showing results (81-90 of 141) with videos related to

Sort By:
Pageof 15
British Journal of Pharmacology|August 1, 1990
Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxanJ Galitzky, J M Senard, M Lafontan, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|January 16, 2002
Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese womenC Sengenes, V Stich, M Berlan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1989
Mechanism of lipolytic action of a new alpha-2 adrenergic antagonist of the piperazinopyrimidine family: RP 55462J S Saulnier-Blache, M Taouis, M Dauzats, et al.
British Journal of Pharmacology|February 1, 1991
Yohimbine increases submaxillary kallikrein release into the saliva in dogs: evidence for alpha 2-adrenoceptor-mediated inhibition of cholinergic pathwaysJ P Girolami, J L Bascands, C Pécher, et al.
British Journal of Clinical Pharmacology|July 1, 1993
Effects of physiological and pharmacological variation of sympathetic nervous system activity on plasma non-esterified fatty acid concentrations in manP Barbe, J Galitzky, D Riviere, et al.
European Journal of Clinical Investigation|December 1, 1985
Platelet alpha 2 adrenoceptors in Parkinson's disease: decreased number in untreated patients and recovery after treatmentA Villeneuve, M Berlan, M Lafontan, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 24, 1999
Increase in epinephrine-induced responsiveness during microgravity simulated by head-down bed rest in humansP Barbe, J Galitzky, C Thalamas, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Pharmacological evidence of alpha 1- and alpha 2-adrenergic supersensitivity in orthostatic hypotension due to spinal cord injury: a case reportJ M Senard, A Arias, M Berlan, et al.
Fundamental & Clinical Pharmacology|September 21, 2001
Changes in vascular alpha 1- and alpha 2-adrenoceptor responsiveness by selegiline treatmentM Pelat, P Verwaerde, M A Tran, et al.
Clinical Neuropharmacology|December 1, 1990
Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatmentG Durrieu, Y Rispail, E Chatelut, et al.
Pageof 15